baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

DE000UK54BA7/ DE000UK54BA7 /

14/06/2024 19:37:13	Chg.+0.080	Bid21:56:35	Ask21:56:35	Underlying	Strike price	Expiration date	Option type
8.190EUR	+0.99%	- Bid Size: -	- Ask Size: -	Johnson and Johnson	232.2951 USD	31/12/2078	Put

GlobeNewswire 28/05 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...

TeleTrader 01/05 J&J to pay $6.5 billion to settle US talc-related lawsuits

GlobeNewswire 17/04 TRC Amends Its Tender Offer for Johnson & Johnson

GlobeNewswire 10/04 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...

TeleTrader 05/04 J&J to acquire Shockwave Medical for $13.1B

TeleTrader 26/03 J&J may allegedly acquire Shockwave Medical

GlobeNewswire 15/03 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists

GlobeNewswire 06/03 Ambrx Shareholders Approve Acquisition by Johnson & Johnson

TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices

TeleTrader 24/01 J&J to pay $149.5M to settle Washington state opioid case

TeleTrader 23/01 J&J to pay $700M in talc powder probe settlement

TeleTrader 23/01 J&J's Q4 sales top estimates, up 7.3% to $21.4B

TeleTrader 23/01 Johnson & Johnson Q4 earnings preview

TeleTrader 22/01 Earnings preview: Tesla takes center stage

TeleTrader 08/01 J&J to buy biotech company Ambrx for $2B

GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...

TeleTrader 07/11/2023 J&J to begin trials with surgical robot

TeleTrader 17/10/2023 J&J's Q3 sales up 6.8% to $21.4 billion

TeleTrader 03/10/2023 J&J's $223.8M talc powder case fine overturned

TeleTrader 29/08/2023 US gov't reveals drugs subject to Medicare price debate

TeleTrader 20/07/2023 J&J highest since January as Q2 results top estimates

TeleTrader 20/07/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion

TeleTrader 18/07/2023 J&J joins drug price suits against US gov't

TeleTrader 04/05/2023 J&J's Kenvue reportedly valued at $41B for IPO

DE000UK54BA7/ DE000UK54BA7 /

If you wish to receive reply to your feedback, please provide your email address.